Stability of HIV-1 RNA in blood during specimen handling and storage prior to amplification by NASBA-QT.
Bruisten SM, Oudshoorn P, van Swieten P, Boeser-Nunnink B, van Aarle P, Tondreau SP, Cuypers HT
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of anticoagulant and storage on the amplification of HIV-1 RNA using the NASBA-QT assay. After experimental storage of whole blood, lysis buffer was added to plasma and specimens were stored at -70 degrees C until analysis.
Summary of Findings
The HIV-1 load was significantly lower in heparinized plasma or serum than in EDTA-plasma (p<0.0001, both). When EDTA-whole blood was stored at 4 degrees for 6-24 h, the HIV-1 RNA levels decreased slightly compared to levels in EDTA-plasma separated immediately, but storage of EDTA-whole blood at 25 degrees C for up to 72 h had no effects on HIV-1 RNA levels. Storage of heparinized whole blood at 4 or 25 degrees C, led to decreased HIV-1 RNA levels starting at 6 h. HIV-1 levels in EDTA-plasma and serum with lysis buffer were stable during 6 months of storage at -70 degrees C, and 14 days of storage at 4 degrees C, but the HIV-1 loads in serum and EDTA-plasma stored with lysis buffer at 30 degrees C were stable for only 1 day.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
FrozenDiagnoses
AIDS/HIV-relatedPlatforms
RNANucleic acid sequence-based amplification (NASBA)Pre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant EDTAHeparinBiospecimen Aliquots and Components Blood and blood products PlasmaSerumWhole bloodBiospecimen Aliquots and Components Centrifugation Centrifugation delays investigatedStorage Storage duration 0 h1 month14 days24 h3 months48 h6 h6 months7 days72 hStorage Storage temperature -70 degrees C25 degrees C30 degrees C4 degrees C